• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年伴有远处转移的胰腺神经内分泌肿瘤患者行原发灶切除术:做还是不做?

Primary site surgery for elderly patients with distant metastatic pancreatic neuroendocrine tumor: to do or not to do?

机构信息

Bachelor of Nursing, Special Medical Department, The Sixth Medical Center of People's Liberation Army General Hospital (The Former Naval General Hospital of PLA), Beijing, People's Republic of China.

Special Medical Department, The Sixth Medical Center of People's Liberation Army General Hospital (The Former Naval General Hospital of PLA), Beijing, People's Republic of China.

出版信息

Clin Interv Aging. 2019 Aug 6;14:1419-1432. doi: 10.2147/CIA.S209428. eCollection 2019.

DOI:10.2147/CIA.S209428
PMID:31496669
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6689544/
Abstract

OBJECTIVE

To investigate the effect of primary site surgery (PSS) on elderly patients (≥65 years) with pancreatic neuroendocrine tumor (pNET) distant metastasis.

PATIENTS AND METHODS

We reviewed Surveillance Epidemiology and the End Results database for elderly patients with distant pNET from 1973 to 2015. The variables and survival outcomes of patients with PSS were compared with that of patients with no PSS. After propensity score matching, the survival outcome was compared again between the two groups. Multivariable Cox proportional hazard model was used to identify variables associated with cancer-specific and overall survival. Four sub-groups were divided according to the age and differentiation: 1) age 65-74 years+ well or moderately differentiated; 2) age ≥75 years+ well or moderately differentiated; 3) age 65-74 years+ poorly differentiated or undifferentiated; and 4) age ≥75 years+ poorly differentiated or undifferentiated. Cancer-specific survival was compared between the patients with and without PSS in the above each group.

RESULTS

A total of 210 elderly patients with distant pNET were finally confirmed. Of which, 148 patients did not undergo PSS, while 62 patients underwent PSS. Being female (=0.049), locating on body/tail of pancreas (=0.006), and well or moderately differentiated (=0.032) were more likely received PSS. The patients underwent PSS had better survival outcomes both before and after propensity score matching. Multivariable Cox proportional hazard analysis proves PSS and higher histological grade to be protective and risk factors. PSS may improve cancer specific survival in patients of group 1), and no improvement was observed in patients of the other three sub-groups.

CONCLUSION

Not all elderly patients with pNET distant metastasis could benefit from PSS. Patients aged 65-74 years with well or moderately differentiated may benefit from primary lesion surgery, but should be evaluated carefully. Prospective randomized controlled trials are worth performing.

摘要

目的

探讨原发灶切除术(PSS)对伴有远处转移的老年胰腺神经内分泌肿瘤(pNET)患者的影响。

方法

我们回顾了 1973 年至 2015 年间,来自监测、流行病学和最终结果(SEER)数据库的伴有远处 pNET 的老年患者资料。比较了行 PSS 与未行 PSS 患者的临床特征及生存情况。采用倾向性评分匹配(PSM)后再次比较两组患者的生存情况。采用多因素 Cox 比例风险模型分析与肿瘤特异性及总生存相关的因素。根据年龄和分化程度将患者分为 4 个亚组:1)年龄 65-74 岁+高或中分化;2)年龄≥75 岁+高或中分化;3)年龄 65-74 岁+低分化或未分化;4)年龄≥75 岁+低分化或未分化。比较各亚组中行 PSS 与未行 PSS 患者的肿瘤特异性生存情况。

结果

共纳入 210 例伴有远处转移的老年 pNET 患者,其中 148 例未行 PSS,62 例行 PSS。行 PSS 的患者女性(P=0.049)、肿瘤位于胰体尾部(P=0.006)、高或中分化(P=0.032)的比例更高。行 PSS 可改善患者的生存情况,且 PSM 前后均如此。多因素 Cox 比例风险分析显示,PSS 和高组织学分级是保护因素和危险因素。PSS 可能改善 1 组患者的肿瘤特异性生存,而在其他 3 个亚组中未观察到改善。

结论

并非所有伴有远处转移的老年 pNET 患者均能从 PSS 中获益。年龄 65-74 岁且高或中分化的患者可能从原发灶手术中获益,但应仔细评估。值得开展前瞻性随机对照临床试验。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20cb/6689544/0741ab0157b5/CIA-14-1419-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20cb/6689544/a523fc541162/CIA-14-1419-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20cb/6689544/9ecb28b602cc/CIA-14-1419-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20cb/6689544/0741ab0157b5/CIA-14-1419-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20cb/6689544/a523fc541162/CIA-14-1419-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20cb/6689544/9ecb28b602cc/CIA-14-1419-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20cb/6689544/0741ab0157b5/CIA-14-1419-g0003.jpg

相似文献

1
Primary site surgery for elderly patients with distant metastatic pancreatic neuroendocrine tumor: to do or not to do?老年伴有远处转移的胰腺神经内分泌肿瘤患者行原发灶切除术:做还是不做?
Clin Interv Aging. 2019 Aug 6;14:1419-1432. doi: 10.2147/CIA.S209428. eCollection 2019.
2
Clinicopathological features and prognosis factors for survival in elderly patients with pancreatic neuroendocrine tumor: A STROBE-compliant article.老年胰腺神经内分泌肿瘤患者的临床病理特征及生存预后因素:一篇遵循STROBE规范的文章
Medicine (Baltimore). 2019 Mar;98(11):e14576. doi: 10.1097/MD.0000000000014576.
3
Neuroendocrine Liver Metastasis: Prognostic Implications of Primary Tumor Site on Patients Undergoing Curative Intent Liver Surgery.神经内分泌肝脏转移:原发肿瘤部位对接受根治性肝切除术患者的预后影响。
J Gastrointest Surg. 2017 Dec;21(12):2039-2047. doi: 10.1007/s11605-017-3491-1. Epub 2017 Jul 25.
4
Survival Benefit of Primary Tumor Resection Among Elderly Patients with Pancreatic Neuroendocrine Tumors.老年胰腺神经内分泌肿瘤患者行原发肿瘤切除术的生存获益。
World J Surg. 2021 Dec;45(12):3643-3651. doi: 10.1007/s00268-021-06281-3. Epub 2021 Aug 11.
5
Clinicopathologic characteristics and prognosis of gastroenteropancreatic neuroendocrine neoplasms: a multicenter study in South China.胃肠胰神经内分泌肿瘤的临床病理特征与预后:一项中国南方的多中心研究
Chin J Cancer. 2017 Jun 21;36(1):51. doi: 10.1186/s40880-017-0218-3.
6
Resection of primary tumor may prolong survival in metastatic gastroenteropancreatic neuroendocrine tumors.原发肿瘤切除术可能延长转移性胃肠胰神经内分泌肿瘤患者的生存时间。
Surgery. 2019 Mar;165(3):644-651. doi: 10.1016/j.surg.2018.09.006. Epub 2018 Oct 23.
7
Outcomes of non-metastatic poorly differentiated gastroenteropancreatic neuroendocrine neoplasms treated with surgery: a real-world population-based study.手术治疗非转移性低分化胃肠胰神经内分泌肿瘤的结果:一项真实世界基于人群的研究。
Int J Colorectal Dis. 2021 May;36(5):941-947. doi: 10.1007/s00384-020-03793-7. Epub 2020 Nov 4.
8
Does surgery provide a survival advantage in non-disseminated poorly differentiated gastroenteropancreatic neuroendocrine neoplasms?手术在非播散性低分化胃肠胰神经内分泌肿瘤中是否具有生存优势?
Surgery. 2021 Jun;169(6):1417-1423. doi: 10.1016/j.surg.2021.01.026. Epub 2021 Feb 23.
9
Resection of the primary tumor improves survival in patients with gastro-entero-pancreatic neuroendocrine neoplasms with liver metastases: A SEER-based analysis.基于 SEER 的分析:原发肿瘤切除术可改善伴肝转移的胃肠胰神经内分泌肿瘤患者的生存。
Cancer Med. 2019 Sep;8(11):5128-5136. doi: 10.1002/cam4.2431. Epub 2019 Jul 22.
10
[Analysis of diagnosis, therapy and prognosis factors of 103 patients with pancreatic neuroendocrine tumors].103例胰腺神经内分泌肿瘤患者的诊断、治疗及预后因素分析
Zhonghua Wai Ke Za Zhi. 2017 Oct 1;55(10):755-759. doi: 10.3760/cma.j.issn.0529-5815.2017.10.008.

引用本文的文献

1
Surgical Versus Nonsurgical Management of Pancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis.胰腺神经内分泌肿瘤的手术治疗与非手术治疗:一项系统评价与Meta分析
Ann Surg Oncol. 2025 Jul 24. doi: 10.1245/s10434-025-17819-3.
2
A Nomogram to Accurately Identify Pancreatic Neuroendocrine Tumors Metastasizing to Distant Organs: A Study Based on Two National Population-Based Cohorts From the United States and China.一种准确识别转移至远处器官的胰腺神经内分泌肿瘤的列线图:一项基于美国和中国两项全国性人群队列的研究
Clin Med Insights Oncol. 2022 May 19;16:11795549221099853. doi: 10.1177/11795549221099853. eCollection 2022.
3

本文引用的文献

1
Pancreaticoduodenectomy and metastasectomy for metastatic pancreatic neuroendocrine tumors.转移性胰腺神经内分泌肿瘤的胰十二指肠切除术和转移灶切除术
J Surg Oncol. 2018 Nov;118(6):983-990. doi: 10.1002/jso.25219. Epub 2018 Sep 13.
2
Liver transplantation for unresectable pancreatic neuroendocrine tumors with liver metastases in an era of transplant oncology.移植肿瘤学时代不可切除的伴有肝转移的胰腺神经内分泌肿瘤的肝移植
Gland Surg. 2018 Feb;7(1):42-46. doi: 10.21037/gs.2017.12.11.
3
Quality of life of elderly patients with solid tumours undergoing adjuvant cancer therapy: a systematic review.
Trends in Incidence and Survival of Patients with Pancreatic Neuroendocrine Neoplasm, 1987-2016.
1987 - 2016年胰腺神经内分泌肿瘤患者的发病率及生存率趋势
J Oncol. 2021 Dec 22;2021:4302675. doi: 10.1155/2021/4302675. eCollection 2021.
接受辅助癌症治疗的老年实体瘤患者的生活质量:一项系统综述。
BMJ Open. 2018 Jan 24;8(1):e018101. doi: 10.1136/bmjopen-2017-018101.
4
Advanced neuroendocrine tumours of the small intestine and pancreas: clinical developments, controversies, and future strategies.小肠和胰腺的高级神经内分泌肿瘤:临床进展、争议和未来策略。
Lancet Diabetes Endocrinol. 2018 May;6(5):404-415. doi: 10.1016/S2213-8587(17)30401-1. Epub 2017 Dec 8.
5
Elderly patients have similar short term outcomes and five-year survival compared to younger patients after pancreaticoduodenectomy.老年患者与年轻患者相比,在胰十二指肠切除术后具有相似的短期结局和五年生存率。
Int J Surg. 2017 Sep;45:138-143. doi: 10.1016/j.ijsu.2017.07.106. Epub 2017 Aug 4.
6
Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States.美国神经内分泌肿瘤患者的发病率、患病率和生存结局趋势。
JAMA Oncol. 2017 Oct 1;3(10):1335-1342. doi: 10.1001/jamaoncol.2017.0589.
7
Differences and Similarities in the Clinicopathological Features of Pancreatic Neuroendocrine Tumors in China and the United States: A Multicenter Study.中国与美国胰腺神经内分泌肿瘤临床病理特征的异同:一项多中心研究
Medicine (Baltimore). 2016 Feb;95(7):e2836. doi: 10.1097/MD.0000000000002836.
8
ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors.《欧洲神经内分泌肿瘤学会功能性胰腺神经内分泌肿瘤和非功能性胰腺神经内分泌肿瘤患者管理共识指南更新》
Neuroendocrinology. 2016;103(2):153-71. doi: 10.1159/000443171. Epub 2016 Jan 5.
9
ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site.ENETS关于肠道、胰腺、支气管神经内分泌肿瘤(NEN)及原发部位不明的NEN远处转移疾病管理的共识指南更新
Neuroendocrinology. 2016;103(2):172-85. doi: 10.1159/000443167. Epub 2016 Jan 5.
10
Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes.探讨神经内分泌肿瘤发病率的上升:基于人群的流行病学、转移表现和结局分析。
Cancer. 2015 Feb 15;121(4):589-97. doi: 10.1002/cncr.29099. Epub 2014 Oct 13.